At least two promising COVID-19 vaccines are in final review by the FDA, whose emergency use authorization will allow for distribution in the United States. In anticipation of an upcoming vaccine, Keck Medicine of USC has been working with university leadership to plan for this major development, including how to distribute the vaccine in the most widely beneficial way possible.
Some details of the complex, fast-moving program are still being finalized. Initial supplies of the vaccine will be limited. Distribution is expected to begin next week and will be prioritized for people with the greatest need.
